Taken together, our experimental and meta-analyses data showed low general levels of ACE2 and TMPRSS2 in all liver cell subsets tested, with upregulation of ACE2 mRNA31,32 and protein in fatty liver disease. This evidence concerns the gene ACE2 and fatty liver disease.